Physical activity associated with less chemo-induced peripheral neuropathy
the ONA take:
Meeting the physical activity guideline was associated with less chemotherapy-induced peripheral neuropathy (CIPN)-like symptoms and a higher health-related quality of life (HRQoL) regardless of treatment with chemotherapy among colorectal cancer survivors, a new study published in the Journal of Cancer Survivorship: Research and Practice has shown.
For the study, researchers in the Netherlands sought to investigate whether there is an association between physical activity, CIPN, and HRQoL among colorectal cancer survivors.
Researchers analyzed data from a Dutch prospective population-based survey among colorectal cancer survivors diagnosed between 2000 and 2009.
Of those, 83% completed the the EORTC QLQ-C30 and the EORTC QLQ-CIPN20 questionnaires. Of those, 31% were treated with chemotherapy.
Results showed that treatment with chemotherapy was associated with a higher number of patients reporting CIPN symptoms regardless of physical activity.
Researchers found that patients treated with chemotherapy who did not complete 150 minutes of moderate to vigorous physical activity a week experienced more CIPN. The study also showed that patients not treated with chemotherapy reported CIPN-like symptoms, especially when they did not complete the 150 minutes/week of exercise.
The findings suggest that health care professionals and colorectal cancer survivors should be aware of the importance of physical activity.
Meeting the physical activity guideline associated with less chemotherapy-induced peripheral neuropathy in colorectal cancer survivors.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Risk for Cardiovascular Disease Higher in Survivors of Testicular Cancer
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|